GIACOMUCCI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 769
EU - Europa 626
AS - Asia 212
OC - Oceania 18
SA - Sud America 2
Totale 1.627
Nazione #
US - Stati Uniti d'America 765
RU - Federazione Russa 403
IT - Italia 73
HK - Hong Kong 65
SG - Singapore 62
IE - Irlanda 51
SE - Svezia 50
CN - Cina 28
ID - Indonesia 19
AU - Australia 18
JO - Giordania 16
FI - Finlandia 14
IN - India 14
DE - Germania 12
KR - Corea 6
GB - Regno Unito 5
CA - Canada 3
ES - Italia 3
NL - Olanda 3
FR - Francia 2
GR - Grecia 2
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
BR - Brasile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
IL - Israele 1
MK - Macedonia 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
VN - Vietnam 1
Totale 1.627
Città #
Santa Clara 475
Chandler 57
Hong Kong 53
Dublin 51
Singapore 50
Ashburn 27
Jakarta 19
Moscow 19
Melbourne 18
Kent 14
Bremen 12
Mumbai 12
Fairfield 11
Helsinki 11
Florence 10
Seattle 10
Altamura 8
Lawrence 8
Shanghai 7
West Jordan 6
Houston 5
Buffalo 4
Princeton 4
Seoul 4
Yubileyny 4
Cambridge 3
Campi Bisenzio 3
Como 3
Lappeenranta 3
Los Angeles 3
L’Aquila 3
Toronto 3
Woodbridge 3
Arezzo 2
Athens 2
Beijing 2
Boardman 2
Boston 2
Colle di Val d'Elsa 2
Dallas 2
Manchester 2
Matelica 2
Medford 2
Milan 2
Monza 2
New York 2
Palermo 2
Poggibonsi 2
Rome 2
Suwon 2
Amsterdam 1
Andover 1
Ann Arbor 1
Bitola 1
Brussels 1
Chennai 1
Chongqing 1
Copenhagen 1
Falls Church 1
Fiesole 1
Harbin 1
Hillsboro 1
Hounslow 1
La Paz 1
Lisbon 1
London 1
Lucca 1
Madrid 1
Norwalk 1
Osimo 1
Panama City 1
Pisa 1
Prague 1
Pune 1
Rio de Janeiro 1
San Diego 1
Soave 1
Sofia 1
Warsaw 1
Washington 1
Wenzhou 1
Wilmington 1
Totale 989
Nome #
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 99
Per2 C111G polymorphism influences cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. A 10-year follow-up study 93
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 89
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 80
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 78
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 77
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 73
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 73
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 73
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 72
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 72
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 69
The Frequency of Intermediate Alleles in Patients with Cerebellar Phenotypes 68
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 66
Intravenous thrombolysis in CADASIL: report of two cases and a systematic review 64
null 63
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol 61
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 56
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment 55
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 51
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns 51
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum? 50
Hidden functional derangement of somatosensory cortices in Alzheimer's Disease 38
Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia 29
Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment 27
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 22
Totale 1.649
Categoria #
all - tutte 7.899
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.899


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202122 4 0 2 2 0 0 0 1 7 3 1 2
2021/202224 0 0 2 0 0 2 0 3 0 2 5 10
2022/2023261 27 43 20 24 20 42 30 14 31 0 10 0
2023/2024201 2 12 17 7 13 19 15 48 2 30 21 15
2024/20251.141 47 138 90 244 351 269 2 0 0 0 0 0
Totale 1.649